KRAS Genotyping in Rectal Adenocarcinoma Specimens With Low Tumor Cellularity After Neoadjuvant Treatment

Modern Pathology- United Kingdom

doi 10.1038/modpathol.2011.210

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Rectal Perforation After Neoadjuvant Chemoradiotherapy for Low-Lying Rectal Cancer

BMJ Case Reports
Medicine
2015English

The Prognostic Significance of Tumor Epidermal Growth Factor Receptor (EGFR) Expression Change After Neoadjuvant Chemoradiation in Patients With Rectal Adenocarcinoma

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2015English

KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer Are Independently Associated With Decreased Response to Neoadjuvant Therapy

Annals of Surgical Oncology
OncologySurgery
2016English

Neoadjuvant Chemoradiotherapy in Combined Treatment of Patients With Rectal Cancer

Grekov's Bulletin of Surgery
2017English

Gene Expression Profiles of Tumor Regression Grade in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy

Oncology Reports
MedicineCancer ResearchOncology
2012English

The Significance of Tumor-Infiltrating Lymphocytes Before and After Neoadjuvant Therapy for Rectal Cancer

Cancer Science
Cancer ResearchMedicineOncology
2018English

Open Versus Laparoscopic Surgery for Low Rectal Cancer After Neoadjuvant Chemoradiotherapy: Short-Term Outcomes

Nippon Daicho Komonbyo Gakkai Zasshi
2012English

Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2016English

“Tumor Regression Grade After Neoadjuvant Chemoradiation and Surgery in Low Rectal Cancer Evaluated by Multiple Correspondence Analysis: Ten Years as Minimum Follow-Up.”

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy